Stay updated on Nivolumab Ipilimumab in CKS Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Ipilimumab in CKS Clinical Trial page.

Latest updates to the Nivolumab Ipilimumab in CKS Clinical Trial page
- CheckyesterdayChange DetectedThe page’s footer revision/version label was updated from v3.5.2 to v3.5.3, indicating a site release without any change to the trial’s displayed study details.SummaryDifference0.1%

- Check8 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check37 days agoChange DetectedFooter revision label updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check51 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. The page content and study details appear unchanged.SummaryDifference0.1%

- Check73 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2.SummaryDifference0.1%

- Check80 days agoChange DetectedFooter revision updated from v3.4.0 to v3.4.1. No changes to the study details, eligibility criteria, or other user-visible content were detected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Nivolumab Ipilimumab in CKS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Ipilimumab in CKS Clinical Trial page.